Total Payments
$1,762
2024 Payments
$119.92
Companies
24
Transactions
100
Medicare Patients
876
Medicare Billing
$91,280
Payment Breakdown by Category
Food & Beverage$1,762 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,762 | 100 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mylan Specialty L.P. | $526.08 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $153.68 | 9 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $152.70 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $143.76 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $139.37 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $73.97 | 4 | $0 (2023) |
| Novo Nordisk Inc | $68.25 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $58.94 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $53.70 | 3 | $0 (2023) |
| ABBVIE INC. | $44.37 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.92 | 6 | Xeris Pharmaceuticals, Inc. ($44.13) |
| 2023 | $609.00 | 33 | Mylan Specialty L.P. ($211.74) |
| 2022 | $665.80 | 41 | Mylan Specialty L.P. ($193.82) |
| 2021 | $366.85 | 20 | Mylan Specialty L.P. ($99.92) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiology | ||||||
| 05/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 10/16/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Biological | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/27/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/20/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Respiratory | ||||||
| 07/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Cardio-renal | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/15/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardio-renal | ||||||
| 05/24/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/10/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 425 | 972 | $86,820 | $45,451 |
| 2022 | 10 | 300 | 637 | $62,339 | $32,482 |
| 2021 | 7 | 151 | 238 | $21,635 | $13,347 |
Total Patients
876
Total Services
1,847
Medicare Billing
$91,280
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 425 | $53,125 | $30,621 | 57.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 147 | $8,085 | $4,599 | 56.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $3,900 | $2,592 | 66.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 14 | $3,010 | $1,750 | 58.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 32 | $2,720 | $1,312 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $3,150 | $1,234 | 39.2% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 29 | 30 | $3,705 | $745.78 | 20.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 29 | 30 | $2,550 | $638.68 | 25.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $510.00 | $476.85 | 93.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 19 | 19 | $510.00 | $387.88 | 76.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 27 | $1,485 | $372.33 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $840.00 | $309.42 | 36.8% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 29 | 30 | $2,100 | $242.53 | 11.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 19 | $665.00 | $157.68 | 23.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 124 | $465.00 | $12.14 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 310 | $38,750 | $19,781 | 51.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 143 | $7,865 | $3,502 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 59 | $5,015 | $3,108 | 62.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $4,350 | $2,861 | 65.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $3,850 | $1,840 | 47.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $570.00 | $501.89 | 88.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $660.00 | $341.78 | 51.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $350.00 | $322.54 | 92.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 15 | $825.00 | $180.08 | 21.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 13 | $104.00 | $44.77 | 43.0% |
About Lindsey Nobles, FNP-C
Lindsey Nobles, FNP-C is a Family healthcare provider based in Magnolia, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2021. The National Provider Identifier (NPI) number assigned to this provider is 1154901445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsey Nobles, FNP-C has received a total of $1,762 in payments from pharmaceutical and medical device companies, with $119.92 received in 2024. These payments were reported across 100 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,762).
As a Medicare-enrolled provider, Nobles has provided services to 876 Medicare beneficiaries, totaling 1,847 services with total Medicare billing of $91,280. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Magnolia, MS
- Active Since 04/11/2021
- Last Updated 04/11/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154901445
Products in Payments
- Yupelri (Drug) $293.74
- YUPELRI (Drug) $232.34
- APTIOM (Drug) $159.53
- XARELTO (Drug) $153.68
- GVOKE HYPOPEN (Drug) $132.81
- BREZTRI (Drug) $87.39
- ENTRESTO (Drug) $73.97
- TRELEGY ELLIPTA (Drug) $53.70
- REXULTI (Drug) $50.48
- Myrbetriq (Drug) $40.90
- Dayvigo (Drug) $39.90
- NURTEC ODT (Drug) $39.67
- Kerendia (Drug) $36.89
- FARXIGA (Drug) $35.85
- Rybelsus (Drug) $32.32
- Nuedexta (Drug) $29.09
- VRAYLAR (Drug) $27.65
- DEXCOM G6 TRANSMITTER (Device) $22.16
- Seglentis (Drug) $20.13
- GVOKE PFS (Drug) $19.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Magnolia
Mrs. Cheryl Wirth, Rn,Fnp-Bc, RN,FNP-BC
Family — Payments: $10,302
Family $10,302
Jerod Mckeehan, Fnp-C, FNP-C
Family — Payments: $7,303
Family $7,303
Mrs. Shawntel Price, Aprn, APRN
Family — Payments: $4,451
Family $4,451
Mrs. Andrea Spurling, Apn, APN
Family — Payments: $3,141
Family $3,141
Samantha Jih, Fnp-C, FNP-C
Family — Payments: $3,120
Family $3,120
Melody Minnick
Family — Payments: $1,898
Family $1,898